AR029091A1 - Uso de compuestos de 1-amino-5-fenilpentano-3-ol y/o 1-amino-6-fenilhexano-3-ol para la preparacion de un medicamento con efecto antagonista de n-metil-d-aspartato-(nmda) - Google Patents
Uso de compuestos de 1-amino-5-fenilpentano-3-ol y/o 1-amino-6-fenilhexano-3-ol para la preparacion de un medicamento con efecto antagonista de n-metil-d-aspartato-(nmda)Info
- Publication number
- AR029091A1 AR029091A1 ARP010102344A ARP010102344A AR029091A1 AR 029091 A1 AR029091 A1 AR 029091A1 AR P010102344 A ARP010102344 A AR P010102344A AR P010102344 A ARP010102344 A AR P010102344A AR 029091 A1 AR029091 A1 AR 029091A1
- Authority
- AR
- Argentina
- Prior art keywords
- amino
- phenylpentane
- nmda
- aspartate
- methyl
- Prior art date
Links
- MQRVXBDFCCKLST-UHFFFAOYSA-N 1-amino-5-phenylpentan-3-ol Chemical compound NCCC(O)CCC1=CC=CC=C1 MQRVXBDFCCKLST-UHFFFAOYSA-N 0.000 title abstract 2
- LKVTZBZZXGPMIC-UHFFFAOYSA-N 1-amino-6-phenylhexan-3-ol Chemical compound NCCC(O)CCCC1=CC=CC=C1 LKVTZBZZXGPMIC-UHFFFAOYSA-N 0.000 title abstract 2
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10025238A DE10025238A1 (de) | 2000-05-22 | 2000-05-22 | Verwendung substituierter 1-Amino-5-phenylpentan-3-ol- und/oder 1-Amino-6-phenylhexan-3-ol- Verbindungen als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR029091A1 true AR029091A1 (es) | 2003-06-04 |
Family
ID=7643080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010102344A AR029091A1 (es) | 2000-05-22 | 2001-05-17 | Uso de compuestos de 1-amino-5-fenilpentano-3-ol y/o 1-amino-6-fenilhexano-3-ol para la preparacion de un medicamento con efecto antagonista de n-metil-d-aspartato-(nmda) |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6784175B2 (fr) |
| EP (1) | EP1289514B1 (fr) |
| JP (1) | JP2004509842A (fr) |
| AR (1) | AR029091A1 (fr) |
| AT (1) | ATE281158T1 (fr) |
| AU (2) | AU2001274022B2 (fr) |
| CA (1) | CA2406198A1 (fr) |
| DE (2) | DE10025238A1 (fr) |
| ES (1) | ES2231502T3 (fr) |
| HU (1) | HUP0301884A2 (fr) |
| MX (1) | MXPA02011410A (fr) |
| NZ (1) | NZ521439A (fr) |
| PE (1) | PE20011261A1 (fr) |
| PT (1) | PT1289514E (fr) |
| UY (1) | UY26718A1 (fr) |
| WO (1) | WO2001089505A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6856700B1 (en) * | 2000-05-24 | 2005-02-15 | Microsoft Corporation | Palettized image compression |
| US9072662B2 (en) | 2004-03-29 | 2015-07-07 | Auris Medical Ag | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| US8268866B2 (en) | 2004-03-29 | 2012-09-18 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| US20060063802A1 (en) | 2004-03-29 | 2006-03-23 | Matthieu Guitton | Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| ME01956B (me) | 2005-09-28 | 2015-05-20 | Auris Medical Ag | Farmaceutske kompozicije za tretman poremećaja unutrašnjeg uva |
| WO2012009258A2 (fr) * | 2010-07-13 | 2012-01-19 | Edward Roberts | Modulateurs des récepteurs à la galanine peptidomimétiques |
| EP2790686B1 (fr) | 2011-12-12 | 2021-03-10 | Zilentin Ag | Traitement de l'acouphène par modulation du co-transporteur chlorure nkcc1 dans le système auditif |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4155935A (en) * | 1973-03-26 | 1979-05-22 | American Home Products Corporation | Benzylamine analgesics |
| US4017637A (en) | 1973-03-26 | 1977-04-12 | American Home Products Corporation | Benzylamine analgesics |
| US4366172A (en) * | 1977-09-29 | 1982-12-28 | The Upjohn Company | 4-Amino-cyclohexanols, their pharmaceutical compositions and methods of use |
| IE913279A1 (en) * | 1990-09-26 | 1992-04-08 | Astra Ab | (2-Thienyl)alkylamine Derivatives Having Neuroprotective¹Properties |
| DE19915601A1 (de) * | 1999-04-07 | 2000-10-19 | Gruenenthal Gmbh | 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung |
-
2000
- 2000-05-22 DE DE10025238A patent/DE10025238A1/de not_active Withdrawn
-
2001
- 2001-05-10 CA CA002406198A patent/CA2406198A1/fr not_active Abandoned
- 2001-05-10 JP JP2001585750A patent/JP2004509842A/ja active Pending
- 2001-05-10 MX MXPA02011410A patent/MXPA02011410A/es active IP Right Grant
- 2001-05-10 NZ NZ521439A patent/NZ521439A/en unknown
- 2001-05-10 AU AU2001274022A patent/AU2001274022B2/en not_active Ceased
- 2001-05-10 PT PT01940450T patent/PT1289514E/pt unknown
- 2001-05-10 HU HU0301884A patent/HUP0301884A2/hu unknown
- 2001-05-10 EP EP01940450A patent/EP1289514B1/fr not_active Expired - Lifetime
- 2001-05-10 US US10/276,617 patent/US6784175B2/en not_active Expired - Fee Related
- 2001-05-10 WO PCT/EP2001/005349 patent/WO2001089505A1/fr not_active Ceased
- 2001-05-10 DE DE50104405T patent/DE50104405D1/de not_active Expired - Fee Related
- 2001-05-10 ES ES01940450T patent/ES2231502T3/es not_active Expired - Lifetime
- 2001-05-10 AT AT01940450T patent/ATE281158T1/de not_active IP Right Cessation
- 2001-05-10 AU AU7402201A patent/AU7402201A/xx active Pending
- 2001-05-17 AR ARP010102344A patent/AR029091A1/es not_active Application Discontinuation
- 2001-05-18 UY UY26718A patent/UY26718A1/es not_active Application Discontinuation
- 2001-05-21 PE PE2001000456A patent/PE20011261A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6784175B2 (en) | 2004-08-31 |
| EP1289514B1 (fr) | 2004-11-03 |
| US20030181450A1 (en) | 2003-09-25 |
| UY26718A1 (es) | 2001-06-29 |
| DE50104405D1 (de) | 2004-12-09 |
| JP2004509842A (ja) | 2004-04-02 |
| DE10025238A1 (de) | 2001-11-29 |
| PE20011261A1 (es) | 2002-01-26 |
| HUP0301884A2 (hu) | 2003-09-29 |
| EP1289514A1 (fr) | 2003-03-12 |
| WO2001089505A1 (fr) | 2001-11-29 |
| MXPA02011410A (es) | 2003-06-06 |
| PT1289514E (pt) | 2005-02-28 |
| NZ521439A (en) | 2005-06-24 |
| CA2406198A1 (fr) | 2002-10-16 |
| AU2001274022B2 (en) | 2004-10-14 |
| ATE281158T1 (de) | 2004-11-15 |
| ES2231502T3 (es) | 2005-05-16 |
| AU7402201A (en) | 2001-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR021981A1 (es) | Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero | |
| BRPI0417717A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| HN2002000300A (es) | Nuevos derivados de piperazina | |
| HN2003000054A (es) | Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas. | |
| CR7820A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos | |
| AR030857A1 (es) | Derivados nitroso de difenolaminas, composiciones farmaceuticas que los contienen y su uso en la preparacion de productos medicinales | |
| UY28342A1 (es) | Nuevos compuestos | |
| UY28348A1 (es) | Compuestos novedosos | |
| HN2002000198A (es) | Composiciones farmaceuticas de amlodipina y atorvastatina | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| ITMI20011337A0 (it) | Composizioni farmaceutiche orali a rilascio modificato del principio attivo | |
| BR0306870A (pt) | Composição farmacêutica oral, e, método para preparar a mesma | |
| HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
| ES2190205T3 (es) | Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda. | |
| ES2187261A1 (es) | Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos. | |
| HN2001000235A (es) | Derivados puentes de piperazina | |
| BR0112847A (pt) | Uso de uma forma de dosagem sólida | |
| AR029091A1 (es) | Uso de compuestos de 1-amino-5-fenilpentano-3-ol y/o 1-amino-6-fenilhexano-3-ol para la preparacion de un medicamento con efecto antagonista de n-metil-d-aspartato-(nmda) | |
| BR0114380A (pt) | Derivados-1-aminobutan-3-ol-substituìdos | |
| UY28422A1 (es) | Sistemas emulsionantes que contienen derivados de azetidina | |
| EA200501565A1 (ru) | Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса | |
| HN2000000057A (es) | Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano. | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
| UY27620A1 (es) | Ambroxoll para el tratamiento de dolores crónicos | |
| ECSP003551A (es) | Complejo farmaceutico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |